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Background: Chalcone, an important intermediate of flavonoid synthetic pathway, has been shown to exhibit
diverse biological and pharmacological activities such as anti- cancer, antioxidant, anti-inflammatory, etc.
Results: In this study, a novel series of chalcones fatty acid esters 5b-e and 6b-e have been synthesized via the reaction
of the respective chalcones with either palmitic or stearic acid. Another related class of compounds comprising 2,3-
disubstituted chalcones 7b-d and 8b(b’)-d as well as 2-amino-6-(substituted-phenyl)-4-substitutedphenyl-nicotinonitrile
derivatives 9a,c,e have been also prepared by both electrophilic and Michael addition reactions, respectively, with the
corresponding chalcones. The structures of all compounds are confirmed via a wide range of spectroscopic techniques
including IR, 1H and 13C NMR, and mass spectra. Significantly, all synthesized compounds have been tested for their
promising antioxidant activities via utilization of 1,1-biphenyl-2-picrylhydrazyl as a free radical scavenging reagent.
Surprisingly, the results demonstrated that compound 5e (68.58% at C = 2 μg/ml) was more effective as an antioxidant
agent than the ascorbic acid, a commonly used antioxidant. Furthermore, the role and contribution of different
functional groups on the antioxidant activity of the synthesized chalcone derivatives are also probed and rationalized in
terms of their electronic and structural effect.
Conclusion: Good activity was noted for chalcone fatty acid esters, with some members recorded higher antioxidant
activity than ascorbic acid.
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Naturally occurring chalcones as well as their synthetic an-
alogues have been shown to exhibit interesting and diverse
biological and pharmacological activities, including anti-
cancer, antioxidant, anti-inflammatory, antimicrobial, and
immunosupportive potential [1-4]. They are absorbed in
the daily diet and appear to be promising cancer chemo-
preventive agents. Generally, chalcones are synthesized by
condensation reaction of aryl ketones and aromatic alde-
hydes, in the presence of suitable condensing agents.
Of particular relevance to the present work is the fact
that the antioxidant properties of chalcones are highly in-
fluenced by the structure of the two aryl moieties in the
backbone, i.e. the substitution on two aryl rings of chalcone* Correspondence: slahsasni@ksu.edu.sa
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article, unless otherwise stated.molecule and their substitution patterns. In this context,
hydroxyl substituent is proven to be one of the key groups
that greatly enhance the antioxidant activity of chalcone as
a result of its facile conversion to the corresponding phe-
noxy radicals through the hydrogen atom transfer mech-
anism [5].
In view of these findings, Torres de Pinedo et al. [6-8]
have investigated the antioxidant activity of several phen-
olic derivatives and found that both dihydrocaffeoyl alcohol
(3-(3,4-dihydroxyphenyl)-1-propanol) and galloyl alcohol
(3,4,5-trihydroxybenzylic alcohol) are stronger antioxidants
than hydroxyl tyrosol in their action as radical-scavengers
and for protecting oil matrix against rancidity.
Owing to the strong demand for new antioxidant agents,
it becomes very critical to explore novel scaffold for the
design and synthesis of new antioxidant agents in order to
help in the battle against pathogenic microorganisms.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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and procedures that enable the synthesis of some new
chalcone fatty acid esters, incorporating fatty acid moiety
directly attached to one of the phenolic positions. Further-
more, in order to understand the structural feature that
makes a compound an effective lipophilic antioxidant, we
have measured the radical-scavenging capacity of chalcone
fatty acid esters having various acylation positions in the
phenol ring along with the length and the nature of the
fatty acid connected to the phenol ring. Finally, to gain
more knowledge about the role of the double bond and
the carbonyl group in the antioxidant activity, various
addition and condensation reactions of the desired chal-
cones have been explored. Importantly, the antioxidant test
used in this study evaluates the capacity of the synthesized
compounds against scavenger 1,1-diphenyl-2-picrylhydrazyl
(DPPH) radical species. DPPH is a stable radical that
presents an absorption maximum at 516 nm [9-11].
Results and discussion
Herein, we report the synthesis of novel series of fatty
acid chalcone esters (5b-e) and (6b-e) by esterification
reactions of some chalcone derivatives with fatty acids.
Then, we prepared the chalcone precursors (3a-e) by
the application of Claisen Schmidt condensation on se-
lected acetophenones (1a-c) and benzaldehydes (2a-d) ac-
cording to literature methods (Scheme 1) [5,11,12]. Details
of the procedures and conditions are illustrated in experi-
mental section.
The synthesis of the desired fatty acid chalcone esters
was then undertaken by esterification reaction of these
freshly prepared chalcone derivatives with stearic or
palmitic chlorides. The stearoyl/palmitoyl chlorides were
prepared from stearic/palmitic acid and thionyl chloride
(SOCl2) according to the literature procedures described
in reference [11]. The stearoyl/palmitoyl chlorides were
then reacted dropwise with the corresponding chalcones
(3b-e) in pyridine, in the presence of dimethyl- amino-











1a   3-OH
1b   4-Br
1c   4-NO2
R R'
2a   3-NO2
2b  3,5-OCH3
2c   4-Br
2d   3-OH
Scheme 1 Preparation of chalcone derivatives.(5b-e) (E)-3-(3-(substituted phenyl)acryloyl)phenyl/(E)-3-
(3-(substituted phenyl)-3-oxoprop-1-en-1-yl)phenyl stearate
(6b-e) compounds, respectively, in very good yields, as il-
lustrated in Scheme 2.
The structures of compounds (5b-e) and (6b-e) were
verified by a combination of IR, and 1H and 13C NMR
spectroscopy.
The synthesis of the corresponding 2,3-dibromo chal-
cones (7b-d) was achieved by electrophilic addition reac-
tion of the initially prepared chalcones (3a-c) and bromine
in chloroform (Scheme 3). Similarly, the chemical struc-
ture of the produced compounds (7b-d) was identified
and confirmed in view of their IR and NMR data.
Disubstitued chalcone derivatives comprising either pi-
peridine or morpholine, namely 2,3-di(morpholin/piperi-
din-1-yl)substituted-1,3-diphenyl-propan-1-one (8b(b’)-d)
were also successfully prepared by the nucleophilic substi-
tution reaction of 2,3-dibromo chalcones (7b-d) by either
piperidine or morpholine in absolute ethanol.
The desired products were isolated and purified by
column chromatography. The synthetic procedures and
reaction conditions for 2,3-di(morpholin/piperidin-1-yl)–
substituted-1,3-diphenyl-propan-1-one 5a-c are illustrated
in Scheme 3. The spectral data (IR, 1H and 13C NMR)
were used to identify the structure of these compounds.
Different synthetic approach has been used for the
synthesis of the nicotinonitrile derivatives. In this re-
gard, the synthesis of 2-amino-6-(substituted-phenyl)-
4-substitutedphenyl nicotinonitrile (9a,c,e) was achieved
by Michael addition reaction of selected chalcones 3a,c,e
with malonitrile in ethanol and in the presence of ammo-
nium acetate (Scheme 4) [15]. The structures of these prod-
ucts were confirmed by their spectral data.
We note that all chalcones synthesis in this work are
used in all reactions but for some of them no result was
found. For example, 3a give no reaction with fatty acid
and 3a and 3e cannot react with bromine. These is can
attribute to the effect of different substituents present in
chalcone derivatives.
In this part, all the synthesized compounds were
assessed for their antioxidant reactivity by monitoringO
R R`
3a-e
3a        3-OH              3-NO2               67
3b        3-OH             3,5-OCH3         60
3c        3-OH              4-Br                85
3d        4-Br               3-OH              79
3e        4-NO2            3-OH              65


















8b      3-OH         3,5-OCH3                              50
8b'      3-OH         3,5-OCH3                            60
8c       3-OH        4-Br                                      56
8d       4-Br          3-OH                                    62





7b      3-OH         3,5-OCH3      80
7c      3-OH         4-Br               82
7d       4-Br          3-OH            90
comp.     R             R'             Yield (%)











5d     4-Br         14.       62
6d     4-Br         16.       66
5e    4-NO2        14.      40




            + 
ClOC(CH2)nCH3
4a-b
5b-c and 6b-c 5d-e and 6d-e
R n
5b     3,5-OCH3         14.       62
6b    3,5-OCH3          16.       48
5c      4-Br                14.        84
6c      4-Br                16.        34
R n
4a: n=14 Palmitoyl chloride
4b: n-16 streatroyl chloride
Yield (%) Yield (%)
Scheme 2 Preparation of compounds (5b-e) and (6b-e).

















3-NO2        48
4-Br          30
3-OH        54
R R`          Yield (%)
Scheme 4 Preparation of compounds (9a,c,e).
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http://journal.chemistrycentral.com/content/8/1/32spectrophotometirically the ability of the compounds to
reduce 2,2-diphenylpicrylhydrazyl (DPPH), a commonly
used radical scavenger.
A comparative assessment of these activities is shown
in Table 1. The data (Table 1) clearly indicate that com-
pounds having a meta ester group on B ring and/or paraTable 1 Antioxidants activities using (DPPH) radical
scavenging method
Radical-scavenging activity% Comp.
2 μg/ml 4 μg/ml 6 μg/ml 8 μg/ml 10 μg/ml
63.10 64.00 64.86 65.81 66.70 ascorbic acid
39.65 44.03 48.85 52.00 56.00 3a
20.89 30.11 40.59 57.56 86.94 3b
43.67 34.78 27.62 19.83 17.81 3c
52.76 58.33 60.43 64.05 67.45 3d
25.26 32.25 33.67 33.51 36.79 3e
36.56 38.43 40.68 43.78 47.02 5b
29.01 32.23 36.43 39.12 51.24 5c
48.82 44.10 33.91 23.46 19.79 5d
68.59 59.33 48.66 40.62 36.23 5e
42.35 46.58 50.40 52.67 55.42 6b
31.18 38.06 45.55 52.29 54.15 6c
62.60 50.21 44.33 40.43 37.21 6d
62.71 58.53 55.62 42.84 38.52 6e
4.81 2.90 2.87 2.84 2.82 7b
6.44 5.58 5.01 4.17 3.68 7c
7.13 7.05 6.89 5.15 4.84 7d
42.87 38.43 35.35 35.16 32.72 8b
26.73 28.59 34.66 46.63 50.25 8b’
34.82 36.22 39.90 40.29 41.39 8c
33.97 30.65 29.23 28.93 24.60 8d
22.88 24.11 27.34 28.44 30.61 9a
12.06 12.12 12.15 15.17 21.91 9c
4.45 5.34 6.42 9.72 10.41 9eelectron-withdrawing substituent as nitro group on A
ring, as proposed for compounds (5d-e and 6d-e), gave
very good activity. In particular, compounds 5e and 6e
showed the strongest inhibition mainly at C = 2 μg/ml as
illustrated in Figure 1. Importantly, the level of activity
of these compounds is very close from the level of ascor-
bic acid particularly at low concentrations. The deceas-
ing of the activities at higher concentrations could arise
from the stearic bulk imparted by the long chain of the
alkyl groups and by the large size of the DPPH.
In contrast, compounds (5b and 6b), with a meta
electron-withdrawing ester group on A, and meta donat-
ing methoxy group on B ring displayed moderate inhib-
ition, but markedly less than ascorbic acid as shown in
Figure 2. This behavior, however, is consistent with that
reported by Murti et al. [9] on the synthesis and anti-
oxidant activity of some chalcones and flavanoids.
Another important factor that affects the antioxidant ac-
tivity of a compound is the nature of the fatty acid moiety.
As can be seen in Figures 1 and 2, the presence of stearate
ester attached to either ring A or B in the most commonly
(excepted 5c at C = 2 μg/ml) synthesized chalcone deriva-
tives has increased the antioxidant activity more than
those containing palmitate ester. These results suggestFigure 1 Antioxidant activity for 5d-e and 6d-e versus
concentration.
Figure 4 The effect of different reaction in the antioxidant
activity.
Figure 2 Antioxidant activity for 5b-c and 6b-c as a function
of concentration.
Figure 3 The effect of different reaction in the antioxidant activity.
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attached to ring A or B in the original chalcones may be
crucial in enhancing their antioxidant reactivity [7,8,10].
In order to test the influence of double bond as well on
the antioxidant activity of chalcone, we assessed the com-
pounds obtained via addition reaction on these double
bonds, i.e., compounds 7b-d and 8b(b')-d. Previous work
has highlighted that electrophilic addition reaction in chal-
cone derivatives, having different substituents, can cause
the antioxidant activity of these derivatives to decrease.
Consistent with this finding, we noted that addition of
bromine to chalcone compound 3c in order to form com-
pound 7c has decreased its activity from 43.67% to 6.44%
particularly, when the concentration (C) is 2 μg/ml. Inter-
estingly, replacing the bromine by the piperidine as is the
case in compound 8c has resulted in marked increase in
the antioxidant activity, leading to a maximum inhibition
of 34.82% at C = 2 μg/ml. On the basis of the overall
results, it can be concluded that the presence of double
bond in chalcone structure is also important to improve
the antioxidant activity [14,15].
Simliarly, we found that the presence of pyridine ring,
cyano group and amino group in 2-amino-6-(substituted-
phenyl)-4-substituted phenyl nicotinonitrile (compound
9c) caused the inhibition to decrease dramatically com-
pared to the parent chalcone 3e i.e., from 43.67% to
12.06% [13,16-18].
Figures 3 and 4 summarize the net effect of the above
mentioned modifications of the chalcone derivatives on
the free radical scavenging activity of DPPH. As can be
seen in Figure 3, for instance, the parent chalcone 3b,
has scavenging activity at C = 10 μg/ml about 86.94%.
Addition of bromine to its double bond has caused its
antioxidant activity to decrease to 2.82%, whereas the
substitution by morpholine or piperidine resulted in an
increase to 32.72% and 50.25%, respectively. On the
other hand, the substitution of hydroxyl group by fatty
acid in ring A or ring B had less effect on the anti-
oxidant activity (47.02% and 55.42% respectively).As for chalcone compound 3e, the substitution of its
hydroxyl group by the fatty acid to yield compound 5e
has increased its antioxidant activity, particularly at C =
2 μg/ml from 25.26% to 68.58%, a value that is higher than
that of ascorbic acid. In the case of compound 6e, an
activity value (62.71%) close to that of ascorbic acid was
obtained. However, upon condensation with malonitrile,
(compound 9e) this value has dramatically decreased to
21.9% as shown in Figure 4. The overall outcome of the
antioxidant activity of this novel series of chalcone-based
fatty acid esters revealed some new very active compounds
that surpass the commonly used antioxidant such as as-
corbic acid. Furthermore, this carefully probed structure-
related activity studies added new insights and rationale to
understand the role and contribution of different func-
tional groups associated with chalcone.
Conclusions
In this work, we have successfully synthesized a novel
series of compounds comprising chalcone fatty acid esters,
2,3-disubstituted chalcones, and 2-amino-6-(substituted-
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class of compounds was prepared by esterification reac-
tions of chalcones with fatty acid chlorides (streatoyl or
palmitoyl) whilst the disubstitued analogues have been
synthesized via electrophilic addition and Michael addition.
The compounds were purified by recrystallization or
column chromatography using appropriate solvent. The
synthetic yields of the generated products ranged from 40
to 90% and their structures were established by spectral
data (IR, NMR, MS). Finally, all of synthesized compound
have been tested for their antioxidant activities using
DPPH method. Good activity was noted for chalcone fatty
acid esters, with some members recorded higher anti-
oxidant activity than ascorbic acid.
Experimental section
General
All chemicals used for the synthesis of the desired com-
pounds were obtained from Merck and SD Fine chemicals.
Melting points were determined using an electrothermal’s
IA9000 series digital capillary melting point apparatus
and used without correction. IR spectra were obtained, as
KBr discs, a 1000-Perkin Elmer FT-IR spectrophotometer.
Spectroscopic data were recorded as follows: 1H and 13C
NMR spectra were acquired on a JEOL ECP-600 NMR in
CDCl3 (or DMSOd6) using TMS as an internal standard.
Chemical shifts are given in δ ppm. Mass spectra were
collected using a direct inlet system (70 eV) with a VL
detector (ES, 4000 V).
General procedure for the synthesis of 1,3-diphenyl-
propenone derivatives 3a-e:
A mixture of NaOH (22 g, 0.55 mol), acetophenone de-
rivatives 1a-c (0.43 mol), benzaldehyde derivatives 2a-d
(0.43 mol) was stirred at 25°C for 2–3 hours and left in
the refrigerator overnight. The precipitated solid was
then filtred off, washed with water and ethanol, dried,
and crystallized from ethanol to yield yellow crystals.
Synthesis of (E)-3-(3-(substitutedphenyl)acryloyl)phenyl or
(E)-3-(3-(substitutedphenyl)-3-oxoprop-1-en-1-yl)phenyl
palmitate stearate (5b-e) and (E)-3-(3-(substitutedphenyl)
acryloyl)phenyl or (E)-3-(3-(substitutedphenyl)-3-oxoprop-1-
en-1-yl)phenyl stearate (6b-e)
To a suspension of fatty acid 4a-b (0.08 mmol) in an-
hydrous CH2Cl2, the thionyl chloride (2.68 mmol)
(0.12 ml) was added at 25°C under argon atmosphere and
the mixture was stirred for 1 hour. One equivalent of the
corresponding chalcone and DMAP in pyridine were then
added and the mixture was stirred for 1 minute. The
organic phase was extracted with water and diethyl ether,
dried with sodium carbonate (Na2SO4), concentrated
to dryness and purified by column chromatography
(hexane–ethyl acetate (9:1) to give 5b-e and 6b-e.(E)-3-(3-(3,5-dimethoxyphenyl)acryloyl)phenyl palmitate (5b)
Yellow powder, yield 62%, m.p. 116°C, m/z% 522 [M+]
C33H46O5, IR (cm
−1): 1702 (C = O) ester and 1654 (C =
O) ketone, 1HNMR (CDCl3): 0.87 (t, 3H, −CH3), 1.24
(m, 24H, −CH2-), 1.62 (qu, 2H, −OCO-CH2-CH2-), 2.34
(t, 2H, −OCO-CH2), 3.83 (s, 6H, OCH3), 6.52 (t, 1H, H-
4), 6.76 (d, 2H, H-2 & H-6), 7.1 (dd, 1H, H-4`), 7.37 (t,
1H, H-5`), 7.45 (d, 1H, J = 15.70 Hz, H-α), 7.55 (s, 1H,
H-2`), 7.58 (d, 1H, H-6`), 7.72 (d, 1H, J = 15.70 Hz, H-β).
13CNMR (CDCl3): 13.2 (−CH3), 21.7 (−CH2-CH3), 23.7
(−CH2-CH2-CH3), 28.5 (−CH2-), 30.9(−CH2-CH2-COO-),
33.1 (−CH2-COO-), 54.5 (−OCH3), 102 (C-4), 105.5 (C-2
& 6), 114.2 (C-2`), 119.4 (C-6`),120.1 (C-4`), 121.5 (C-α),
129 (C-5`), 135.7 (C-1), 138.5 (C-1`), 144.4 (C-β), 155.4
(C-3`), 160.1 (C-3 & 5), 179.2 (−COO-), 189.7 (−C =O).
(E)-3-(3-(4-bromophenyl)acryloyl)phenyl palmitate (5c)
Yellow powder, yield 84%, m.p. 126°C, m/z% 540 [M+]
C31H41BrO3, IR (cm
−1): 1702 (C = O) ester and 1654
(C = O) ketone, 1HNMR (CDCl3): 0.87 (t, 3H, −CH3),
1.24 (m, 24H, −CH2-), 1.62 (qu, 2H, −OCO-CH2-CH2-),
2.34 (t, 2H, −OCO-CH2), 7.08 (d, 1H, H-4`), 7.39
(t, 1H, H-5`), 7.52 (m, 7H, H-2, 6, 3, 5, α, 2`, 6`), 7.74
(d, 1H, J = 15.60 Hz, H-β). 13CNMR (CDCl3): 13.0
(−CH3), 21.6 (−CH2-CH3), 23.6 (−CH2-CH2-CH3), 28.4
(−CH2-), 30.6 (−CH2-CH2-COO-), 33.1 (−CH2-COO-),
113.8 (C-2`), 119.5 (C-α), 119.8 (C-6`), 121.2 (C-4`),
123.9 (C-4), 128.6 (C-2,6 & C-5`), 131.1 (C-3,5), 132.5
(C-1), 138.3 (C-1`), 142.4 (C-β), 155.4 (C-3`), 175.4
(−COO-), 189.3 (−C =O).
(E)-3-(3-(4-bromophenyl)-3-oxoprop-1-en-1-yl)phenyl
palmitate (5d)
Yellow powder, yield 62%, m.p. 132°C, m/z% 540 [M+]
C31H41BrO3, IR (cm
−1): 1704 (C =O) ester and 1652
(C =O) ketone, 1HNMR (CDCl3): 0.83 (t, 3H, −CH3), 1.24
(m, 28H, −CH2-), 1.59 (qu, 2H, −OCO-CH2-CH2-), 2.31
(t, 2H, −OCO-CH2), 6.89 (d, 1H, H-4), 7.11 (s, 1H, H-2),
7.18 (d, 1H, H-6), 7.26 (t, 1H, H-5), 7.41 (d, 1H,
J = 15.70 Hz, H-α), 7.61 (d, 2H, J = 8.00 Hz, H-3`&5`), 7.73
(d, 1H, J = 15.70 Hz, H-β), 7.85 (2H, d, J = 8.00 Hz, H-2`&
6`). 13CNMR (CDCl3): 12.9 (−CH3), 21.5 (−CH2-CH3),
23.5 (−CH2-CH2-CH3), 28.5 (−CH2-), 30.7 (−CH2-CH2-
COO-), 32.8 (−CH2-COO-), 113.8 (C-2), 116.9 (C-4),
120.2 (C-6), 120.6 (C-α), 128.9 (C-2`& 6`), 129.1 (C-
5),130.8 (C3`& 5`), 134.9 (C-4`), 135.2 (C-1), 136.8 (C-1`),
144.1 (C-β), 155 (C-3), 178.4 (−COO-), 188.4 (−C =O).
(E)-3-(3-(4-nitrophenyl)-3-oxoprop-1-en-1-yl)phenyl
palmitate (5e)
Orange powder, yield 40%, m.p. 182°C, m/z% 507 [M+]
C31H41NO5, IR (cm
−1): 1701 (C =O) ester and 1653
(C =O) ketone, 1HNMR (CDCl3): 0.85 (t, 3H, −CH3), 1.22
(m, 24H, −CH2-), 1.46 (qu, 2H, −OCO-CH2-CH2-), 2.17
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7.27 (d, 1H, H-6), 7.33 (t, 1H, H-5), 7.70 (d, 1H,
J = 15.50 Hz, H-α), 7.86 (d, 1H, J = 15.50 Hz, H-β), 8.36
(m, 4H, H-2`, 6`, 3`&5`). 13CNMR (CDCl3): 13.3 (−CH3),
21.4 (−CH2-CH3), 23.8 (−CH2-CH2-CH3), 28.1 (−CH2-),
30.6 (−CH2-CH2-COO-), 33.0 (−CH2-COO-), 114.5 (C-2),
118.1 (C-4), 119.8 (C-6), 121.2 (C-α), 123.2 (C-2`& 6`),
129.1 (C-5), 129.3 (C3`& 5`), 135 (C-1), 141.6 (C-1`),
145.3 (C-β), 149.2 (C-3), 157.4 (C-4`), 173.8 (−COO-),
187.9 (−C =O).
(E)-3-(3-(3,5-dimethoxyphenyl)acryloyl)phenyl stearate (6b)
Yellow powder, yield 48%, m.p. 114°C, m/z% 540 [M+]
C35H50O5, IR (cm
−1): 1705 (C =O) ester and 1654
(C = O) ketone, 1HNMR (CDCl3): 0.87 (t, 3H, −CH3),
1.24 (m, 28H, −CH2-), 1.62 (qu, 2H, −OCO-CH2-CH2-),
2.34 (t, 2H, −OCO-CH2), 3.83 (s, 6H, OCH3), 6.52
(t, 1H, H-4), 6.76 (d, 2H, H-2 & H-6), 7.1 (dd, 1H,
H-4`), 7.38 (t, 1H, H-5`), 7.44 (d, 1H, J = 15.30 Hz, H-α),
7.55 (d, 1H, H-6`), 7.58 (s, 1H, H-2`), 7.72 (d, 1H,
J = 15.3 Hz, H-β). 13CNMR (CDCl3): 13.1 (−CH3), 21.7
(−CH2-CH3), 23.7 (−CH2-CH2-CH3), 28.1 (−CH2-), 30.9
(−CH2-CH2-COO-), 33.1 (−CH2-COO-), 54.5 (−OCH3),
101.9 (C-4), 105.4 (C-2 & 6), 114.1 (C-2`), 1119.2
(C-6`), 120.1 (C-4`), 121.4 (C-α), 128.9 (C-5`), 135.6 (C-1),
138.7 (C-1`), 144.2 (C-β), 155.1 (C-3`), 160 (C-3 & 5),
179.5 (−COO-), 189.6 (−C=O).
(E)-3-(3-(4-bromophenyl)acryloyl)phenyl stearate (6c)
Yellow powder, yield 34%, m.p. 120°C, m/z% 568 [M+]
C33H45BrO3, IR (cm
−1): 1702 (C =O) ester and 1654 (C =
O) ketone, 1HNMR (CDCl3): 0.87 (t, 3H, −CH3), 1.24
(m, 28H, −CH2-), 1.62 (qu, 2H, −OCO-CH2-CH2-), 2.34
(t, 2H, −OCO-CH2), 7.11 (d, 1H, H-4`), 7.37 (t, 1H, H-5`),
7.51 (m, 7H, H-2, 6, 3, 5, α, 2`, 6`), 7.74 (d, 1H, J =
15.70 Hz, H-β). 13CNMR (CDCl3): 13.0 (−CH3), 21.6
(−CH2-CH3), 23.6 (−CH2-CH2-CH3), 28.3 (−CH2-), 30.8
(−CH2-CH2-COO-), 33.1 (−CH2-COO-), 114.1 (C-2`),
119.5 (C-α), 119.9 (C-6`), 121.3 (C-4`), 123.9 (C-4), 128.8
(C-2,6 & C-5`), 131.1 (C-3,5), 132.6 (C-1), 138.3 (C-1`),
142.8 (C-β), 155.2 (C-3`), 175.4 (−COO-), 189.3 (−C =O).
(E)-3-(3-(4-bromophenyl)-3-oxoprop-1-en-1-yl)phenyl
stearate (6d)
Yellow powder, yield 66%, m.p. 136°C, m/z% 568 [M+]
C33H45BrO3, IR (cm
−1): 1704 (C =O) ester and 1652
(C =O) ketone, 1HNMR (CDCl3): 0.87 (t, 3H, −CH3), 1.24
(m, 28H, −CH2-), 1.62(qu, 2H, −OCO-CH2-CH2-), 2.34
(t, 2H, −OCO-CH2), 6.91 (d, 1H, H-4), 7.14 (s, 1H, H-2),
7.20 (d, 1H, H-6), 7.29 (t, 1H, H-5), 7.44 (d, 1H,
J = 15.70 Hz, H-α), 7.64 (d, 2H, J = 8.40 Hz, H-3`& 5`),
7.76 (d, 1H, J = 15.70 Hz, H-β), 7.87 (2H, d, J = 8.40 Hz,
H-2`& 6`). 13CNMR (CDCl3): 12.9 (−CH3), 21.5 (−CH2-
CH3), 23.5 (−CH2-CH2-CH3) , 28.2 (−CH2-), 30.8 (−CH2-CH2-COO-), 32.8 (−CH2-COO-), 113.8 (C-2), 116.8 (C-4),
120.1 (C-6), 120.6 (C-α), 128.9 (C-2`& 6`), 129.1 (C-5),
130.8 (C3`& 5`), 135 (C-4`), 135.6 (C-1), 137 (C-1`), 144.1
(C-β), 155 (C-3), 178.4 (−COO-), 188.5 (−C=O).
(E)-3-(3-(4-nitrophenyl)-3-oxoprop-1-en-1-yl)phenyl
stearate (6e)
Yellow powder, , yield 54%, m.p. 184°C, m/z% 535 [M+]
C33H45NO5, IR (cm
−1): 1703 (C =O) ester and 1653
(C =O) ketone, 1HNMR (CDCl3): 0.87 (t, 3H, −CH3), 1.24
(m, 24H, −CH2-), 1.62 (q, 2H, −OCO-CH2-CH2-), 2.34
(t, 2H, −OCO-CH2), 6.90 (d, 1H, H-4), 7.25 (s, 1H, H-2),
7.29 (d, 1H, H-6), 7.31 (t, 1H, H-5), 7.70 (d, 1H,
J = 15.50 Hz, H-α), 7.84 (d, 1H, J = 15.50 Hz, H-β), 8.36
(m, 4H, H-2`, 6`, 3` &5`).13CNMR (CDCl3): 13.2 (−CH3),
21.5 (−CH2-CH3), 23.6 (−CH2-CH2-CH3), 28.2 (−CH2-),
30.7 (−CH2-CH2-COO-), 32.8 (−CH2-COO-), 114.7 (C-2),
117.6 (C-4), 119.5 (C-6), 121 (C-α), 123.1 (C-2`& 6`), 128.8
(C-5), 129.2 (C3`& 5`), 135 (C-1), 141.7 (C-1`), 145.1 (C-β),
149.1 (C-3), 157.1 (C-4`), 173.7 (−COO-), 187.7 (−C=O).
Synthesis of 2,3-Dibromo-1,3-diphenyl-propan-1-one
derivatives (7b-d)
A mixture of chalcones derivatives 3b-d (1 mmol) and
bromine (2 ml) in chloroform (25 ml) was stirred for 1–
4 h. After cooling, ethanol was added and the precipi-
tated solid was collected by filtration. Recrystallization
from ethanol afforded 2,3-dibromo-1,3-diphenyl-propan-
1-one derivatives as white powder 7b-d.
2,3-Dibromo-3-(3,5-dimethoxy-phenyl)-1-(3-hydroxy-phenyl)-
propan-1-one (7b)
White powder, yield 80%, m.p. 236°C, m/z% 442 [M+]
C17H16Br2O4, IR (cm
−1): 3410 (OH) and 1711 (C = O)
ketone, 1HNMR (CDCl3): 3.95 (s, 6H, −OCH3), 6.18
(s, 1H, H-2), 6.34 (s, 1H, H-6), 6.56 (d, 1H, H-4), 6.76
(d, 1H, H-4'), 6.85 (d, 1H, J = 11.40 Hz, H-β), 6.86 (t, 1H,
H-5'), 7.02 (d, 1H, J = 11.40 Hz, H-α), 7.78 (s, 2H, H-2' &
H-6'). 13CNMR (CDCl3): 45.78 (C-β), 48.07 (C-α), 56.71
(−OCH3), 96.91 (C-4), 105.32 (C-2), 107.7 (C-6), 112.31
(C-2'), 122.08 (C-4'), 131.94 (C-6'), 135.9 (C-5'), 136.8
(C-1'), 138.32 (C-1), 150.04 (C-3'), 156.11 (C-3), 156.38
(C-5), 188.94 (C =O).
2,3-Dibromo-3-(4-bromo-phenyl)-1-(3-hydroxy-phenyl)-
propan-1-one (7c)
White powder, yield 82%, m.p. >300°C, m/z% 460 [M+]
C15H11Br3O2, IR (cm
−1): 3461 (OH) and 1709 (C = O)
ketone, 1HNMR (CDCl3): 5.56 (d,1H, J = 10.80 Hz, H-β),
6.01 (d, 1H, J = 10.80 Hz, H-α), 7.41 (d, 2H, J = 8.40 Hz,
H-2 & H-6), 7.53 (d, 2H, J = 8.40 Hz, H-3 & H-5), 7.60
(d, 1H, H-4'), 7.72 (t, 1H, H-5'), 7.78 (s, 1H, H-2'), 7.81
(d, 1H, H-6').13CNMR (CDCl3): 46.95 (C-β), 51.96 (C-α),
114.42 (C-2'), 122.7 (C-4'), 129.92 (C-2& C-6), 131.7
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137.9 (C-1), 138.01 (C-1'), 151.43 (C-3'), 189.38 (C = O).
2,3-Dibromo-1-(4-bromo-phenyl)-3-(3-hydroxy-phenyl)-
propan-1-one (7d)
White powder, yield 90%, m.p. >300°C, m/z% 460 [M+]
C15H11Br3O2, IR (cm
−1): 3447 (OH) and 1683 (C =O)
ketone, 1HNMR (CDCl3): 6.21 (d, 1H, H-4), 6.61 (s, 1H,
H-2), 6.64 (d, 1H, J = 11.40 Hz, H-β), 6.67 (d, 1H,
J = 11.40 Hz, H-α), 7,66 (t, 1H, H-5), 7.70 (d, 2H, J = 8.50
Hz, H-3' & H-5'), 7.84 (d, 1H, H-6), 7.93 (d, 2H, J =
8.50 Hz, H-2' & H-6'). 13CNMR (CDCl3): 42.4 (C-β), 46.85
(C-α), 111.1 (C-4), 112.5 (C-2), 114.95 (C-6),117.4 (C-4'),
130.36 (C-2' & C-6'), 132.45 (C-3' & C-5'), 132.78 (C-5),
135.5 (C-1'), 137.01 (C-1), 149.84 (C-3), 189.26 (C =O).
Synthesis of 2,3-Disubstituted-1,3-diphenyl-propan-1-one
derivatives (8b(b’)-d)
A mixture of 2,3-dibromo-1,3-diphenyl-propan-1-one
derivatives 7a-c (0.01 mol) and morpholine or pepiridine
(0.01 mol) in ethanol (10 ml) was heated in oil-bath for
5 h. After cooling, 50 ml of water was added and the or-
ganic phase was extracted, then washed with 10% of
hydrochloric acid (HCl) (3 × 50 ml), dried with sodium
carbonate (Na2SO4) and concentrated to dryness. The
isolated solid was then purified by column chromatog-
raphy on silica gel using ethyl acetate/hexane (3:7) as
eluent to give 2,3-disubstituted-1,3-diphenyl-propan-1-
one derivatives 8a-d as yellow powders.
3-(3,5-Dimethoxy-phenyl)-1-(3-hydroxy-phenyl)-2,3-di-
piperidin-1-yl-propan-1-one (8b)
Yellow-orange powder, yield 50%, m.p. 225°C, m/z% 452
[M+] C27H36N2O4, IR (cm
−1): 3427 (OH) and 1634 (C =
O) ketone, 1HNMR (CDCl3): 1.25 (s, 12H, H-3-5 for pi-
peridine), 1.66 (t, 8H, H-2 and H-6 for piperidine), 3.13
(d, 1H, H-β), 3.52 (d, 1H, H-α), 3.93 (s, 6H, −OCH3),
5.27 (s, 2H, H-2 & H-6), 5.52 (s, 1H, H-4), 6.58 (s, 2H,
H-4' & H-5'), 7.62 (s, 2H, H-2' & H-6'). 13CNMR
(CDCl3): 24.1 (C-3 for piperidine), 25.1 (C-5 for piperi-
dine), 26.2 (C-4 for piperidine), 37.1 (C- β), 44.6 (C-α),
47.5 (C-6 for piperidine), 48.2 (C-2 for piperidine), 56.5
(−OCH3), 101.9 (C-4),108.2 (C-2), 108.3 (C-6), 109.6
(C-2'), 121 (C-4'), 134.8 (C-5' & C-6'), 139.4 (C-1'), 146
(C-1), 148.3 (C-3'), 156.3(C-3 & C-5), 187.8 (C =O).
3-(3,5-Dimethoxy-phenyl)-1-(3-hydroxy-phenyl)-2,3-di-
morpholin-4-yl-propan-1-one (8b’)
Yellow powder, yield 60%, m.p. 253°C, m/z% 456 [M+]
C25H32N2O6, IR (cm
−1): 3424 (OH) and 1642 (C =O) ke-
tone, 1HNMR (CDCl3): 3.01 (s, 8H, H-2 and H-6 for mor-
pholine) , 3.41 (d, 1H, H-β), 3.58 (d, 1H, H-α), 3.77 (s, 8H,
H-3 and H-5 for morpholine), 3.97 (s, 6H, −OCH3), 5.41
(s, 2H, H-2 & H-6), 5.59 (s, 1H, H-4), 6.62 (s, 2H, H-4' &H-5'), 7.53 (s, 2H, H-2' & H-6').13CNMR (CDCl3): 40.6
(C-β), 44,5 (C-2 and C-6 for morpholine), 45.8 (C-α), 56.6
(−OCH3), 65.5 (C-3 and C-5 for morpholine), 96.9 (C-4),
101.8 (C-2), 101.9 (C-6), 111.2 (C-2'), 114.3 (C-4'), 134.3
(C-5' & C-6'), 138.9 (C-1'), 144.7 (C-1), 157 (C-3'), 160.9
(C-3& C-5), 188.1 (C =O).
3-(4-Bromo-phenyl)-1-(3-hydroxy-phenyl)-2,3-di-piperidin-1-
yl-propan-1-one (8c)
Yellow powder, yield 56%, m.p. 220°C, m/z% 470 [M+]
C25H31BrN2O2, IR (cm
−1): 3447 (OH) and 1656 (C =O)
ketone, 1HNMR (CDCl3): 1.25 (s, 12H, H-2, H-3, H-5 and
H-6 for piperidine), 1.73 (t, 8H, H-2 and H-6 for piperi-
dine), 4.37 (s, 1H, H-β), 4.38 (s, 1H, H-α), 7.47 (d, 2H, J =
8.40 Hz, H-2 & H-6), 7.51 (d, 2H, J = 8.40 Hz, H-3 & H-5),
7.49 (d, 1H, H-4'), 7.67 (t, 1H, H-5'), 7.74 (s, 1H, H-2'),
7.85 (d, 1H, H-6'). 13CNMR (CDCl3): 24.3 (C-3 for piperi-
dine), 25.4 (C-5 for piperidine), 26.4 (C-4 for piperidine),
37.1 (C- β), 44.6 (C-α), 47.1 (C-6 for piperidine), 47.6 (C-2
for piperidine), 118.1 (C-2'), 122.9 (C-4'), 131.4 (C-2&
C-6), 131.5 (C-3& C-5), 131.9 (C-6'), 132.2 (C-4), 134.1
(C-5'), 135.1 (C-1), 135.2 (C-1'), 149.3 (C-3'), 193.7 (C =O).
1-(4-Bromo-phenyl)-3-(3-hydroxy-phenyl)-2,3-di-morpholin-
4-yl-propan-1-one (8d)
Yellow-orange powder, yield 62%, m.p. 245°C, m/z% 574
[M+] C23H27BrN2O4, IR (cm
−1): 3442 (OH) and 1651 (C =
O) ketone, 1HNMR (CDCl3): δ 2.59 (s, 8H, H-2 and H-6
for morpholine), 3.77 (s, 8H, H-3 and H-5 for morpho-
line), 4.27 (s, 1H, H-β), 4.47 (s, 1H, H-α), 6.05 (s, 2H, H-2
& H-4), 7.51 (d, 2H, J = 8.50 Hz, H-3' & H-5'), 7.59 (t, 1H,
H-5), 7.70 (d, 2H, J = 8.50 Hz, H-2' & H-6'), 7.72 (d, 1H,
H-6) ppm. 13CNMR (CDCl3): δ 40.4 (C-β), 43.6 (C-2 and
C-6 for morpholine), 46.6 (C-α), 64.6 (C-3 and C-5 for
morpholine), 111.4 (C-2 & C-4), 111.8 (C-6), 112.1 (C-4'),
129.1 (C-2'& C-6'), 131.2 (C-3' & C-5'), 134.8 (C-5), 137.8
(C-1'), 139.6 (C-1), 159.5 (C-3), 185.1 (C =O) ppm.
Synthesis of 2-amino-4,6-diphenyl-nicotinonitrile derivatives
(9a,c,e)
A mixture of chalcones 3a, c and f (10 mmol), malononi-
trile (10 mmol) and ammonium acetate (80 mmol) in
ethanol (50 ml) was heated under reflux for 5 h. The solid
product was filtered off, washed with ethanol, dried and




Brown powder, yield 48%, m.p. 286°C, m/z% 332 [M+]
C18H12N4O3, IR (cm
−1): 3440 (OH), 3253, 3357 (NH2),
2216 (CN), 1653 (C =N), 1HNMR (CDCl3): δ 6.96
(m, 4H, H-5, H-2', H-4', H-6'), 7.07 (s, 2H, NH2), 7.32
(t, 1H, H-5'), 7.83 (t, 1H, H-5"), 8.11 (d, 1H, H-6"), 8.36
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13CNMR (CDCl3): δ 93.9 (C-3), 114.5 (C-4'), 114.9 (C-5),
115.7 (C-2'), 117.7 (CN),118.4 (C-6'), 122.6 (C-2"), 123.3
(C-4"), 129 (C-5"), 129.5 (C-5'), 134.5 (C-6"), 137.7
(C-1"), 138 (C-1'), 147 (C-3"), 149.4 (C-4), 153.2 (C-3'),
156.6 (C-6), 171.7 (C-2) ppm.
2-Amino-4-(4-bromo-phenyl)-6-(3-hydroxy-phenyl)-
nicotinonitrile (9c)
Yellow-green powder, yield (30%), m.p. 250°C, m/z% 395
[M+] C18H12BrN3O, IR (cm
−1): 3431 (OH), 3226, 3335
(NH2), 2216 (CN), 1653 (C =N),
1H NMR (CDCl3): δ 6.88
(d, 1H, H-6'), 7.05 (s, 2H, NH2), 7,18 (s, 1H, H-2'), 7.28
(t, 1H, H-5'), 7.51 (s, 1H, H-5), 7.53 (d, 1H, H-4'), 7.64
(d, 2H, J = 9.00 Hz, H-2" & 6"), 7.77 (d, 2H, J = 9.00 Hz,
H-3"& 5"), 9.63 (s, 1H, OH) ppm. 13CNMR (CDCl3): δ
85.8 (C-3), 108.7 (C-2'), 113.6 (C-5), 116.4 (CN),116.7
(C-4'), 117.7 (C-6'), 122.7 (C-4"), 129.1 (C-5'), 130.1
(C-2"&C-6"), 131.3 (C-3"&C-5"), 135.4 (C-1"), 138.4 (C-1'),
152.9 (C-4), 157.2 (C-3'), 158.5 (C-6), 160.3 (C-2) ppm.
2-Amino-4-(3-hydroxy-phenyl)-6-(4-nitro-phenyl)-
nicotinonitrile (9e)
Brown powder, yield 54%, m.p. 230°C, m/z% 332 [M+]
C18H12N4O3, IR (cm
−1): 3388 (OH), 3242, 3388 (NH2),
2218 (CN), 1635 (C =N), 1H NMR (CDCl3): δ 6.82
(s, 1H, H-2"), 6.97 (m, 3H, H-4", H-6", H-5), 7.04 (s, 2H,
NH2), 7.32 (t, 1H, H-5"), 8.35 (m, 4H, H-2', 6' & H-3', H
5'), 9.81 (s, 1H, OH) ppm. 13CNMR (CDCl3): δ 98.2
(C-3), 114.6 (C-5), 115.1 (C-2"), 115.9 (C-4"), 117.6
(CN),118.6 (C-6"), 123.1 (C-3'&C-5'), 129.2 (C-5"), 129.6
(C-2'&C-6'), 137.9 (C-1"), 143.1 (C-1'), 147.1 (C-4'),
153.4 (C-4), 156.3 (C-3'), 158.3 (C-6), 163.5(C-2) ppm.
Preparation of different simples to assess the antioxidant
activity
Stock solution of free radical scavenger 2,2-diphenylpicryl-
hydrazyl (DPPH) 100 μL was added to 3.0 ml of methanol
and the absorbance was recorded at 516 nm by UV–VIS
spectrophotometer. Different concentrations of the syn-
thesized compounds (2, 4, 6, 8, and 10 μ g/ml) were pre-
pared also in methanol. All sample solutions, 1.0 ml each,
is diluted with 3.0 ml methanol and 100 μL DPPH was
added. The test tubes were kept for 30 min in the dark to
complete the reaction. The absorbance of each test tube
was recorded at 517 nm on UV–VIS spectrophotometer
against methanol as a blank. The DPPH free radical scav-
enging activity was calculated using the following formula:





100Where: control is absorbance of a DPPH solution with-
out compound and ascorbic acid was used as the free
radical scavenger reference compound.
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